Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Affinitak + Chemo in Advanced NSCLC
NCT00017407Phase 3Completed
- Sponsor
- Ionis Pharmaceuticals
- Start
- Oct 2000
- Primary completion
- Sep 2002
- Modality
- Modified DNA Oligonucleotides, Single-strand DNA, Antisense Oligonucleotides (ASOs)
- Countries
- 1
01
Overview
A Phase 3 trial of aprinocarsen in non-small cell lung cancer (NSCLC), sponsored by Ionis Pharmaceuticals. Started Oct 2000; status: completed.
02
Drugs
aprinocarsen
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00017407.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00017407.